Advertisement
Advertisement

TENX

TENX logo

Tenax Therapeutics, Inc.

12.48
USD
Sponsored
-0.45
-3.44%
Jun 25, 12:26 UTC -4
Open

TENX Earnings Reports

Positive Surprise Ratio

TENX beat 22 of 39 last estimates.

56%

Next Report

Date of Next Report
Aug 11, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.38
Implied change from Q1 26 (Revenue/ EPS)
--
/
+8.57%
Implied change from Q2 25 (Revenue/ EPS)
--
/
+40.74%

Tenax Therapeutics, Inc. earnings per share and revenue

On May 12, 2026, TENX reported earnings of -0.35 USD per share (EPS) for Q1 26, beating the estimate of -0.40 USD, resulting in a 14.22% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.84% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.38 USD, with revenue projected to reach -- USD, implying an increase of 8.57% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q1 2026, Tenax Therapeutics, Inc. reported EPS of -$0.35, beating estimates by 14.22%, and revenue of $0.00, 0% as expectations.
The stock price moved up 1.84%, changed from $11.95 before the earnings release to $12.17 the day after.
The next earning report is scheduled for Aug 11, 2026.
Based on 4 analysts, Tenax Therapeutics, Inc. is expected to report EPS of -$0.38 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement